General Information of Drug (ID: DMG78U2)

Drug Name
2-Hydrazinocarbonyl-benzenesulfonamide Drug Info
Synonyms
102169-52-8; 2-(hydrazinecarbonyl)benzenesulfonamide; 2-(hydrazinocarbonyl)benzenesulfonamide; 2-Hydrazinocarbonyl-benzenesulfonamide; 2-(hydrazinecarbonyl)benzene-1-sulfonamide; Benzoic acid,2-(aminosulfonyl)-, hydrazide; hydrazide deriv. 6; AC1M8OJR; ACMC-1BW2D; AC1Q54UM; Oprea1_607731; CHEMBL361191; CTK4A0755; BDBM12153; DTXSID30368807; HMS1788K01; ZX-AN012798; ZINC3372954; ALBB-014056; 7604AC; STL301522; AKOS000116142; FCH1317207; MCULE-6758898279; 2-(hydrazinylcarbonyl)benzenesulfonamide; BBV-40193034; Benzoic acid, 2-(aminosul
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
2490720
CAS Number
CAS 102169-52-8
TTD Drug ID
DMG78U2

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Carbonic anhydrase II (CA-II) TTANPDJ CAH2_HUMAN Inhibitor [1]
Carbonic anhydrase IX (CA-IX) TT2LVK8 CAH9_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Carbonic anhydrase II (CA-II) DTT CA2 8.796 10.933 9.395 9.819
Carbonic anhydrase IX (CA-IX) DTT CA9 5.04 6.156 4.609 6.756
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Carbonic anhydrase II (CA-II) DTT CA2 7.95E-08 0.52 0.33
Carbonic anhydrase IX (CA-IX) DTT CA9 1.12E-10 -0.03 -0.09
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamide... J Med Chem. 2005 Mar 24;48(6):2121-5.